Advisory Committee Meeting; Amendment of Notice

Riepilogo

The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Antiviral Drugs Advisory Committee. This meeting was announced in the Federal Register of June 24, 1994 (59 FR 32699 at 32700). The amendment is being made to reflect a change in the date of the meeting from a 1-day to a 2-day meeting and a change in the meeting room locations, and to announce a closed portion of the meeting, which is now scheduled for the second day. The open committee discussion remains the same, except for the date the discussions will be held. This amendment will be announced at the beginning of the open portion of the meeting.